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Running Head: Regulation of oocyte quality by cAMP/cGMP  28 
 29 
Abstract  30 
 31 
The cyclic nucleotides, cAMP and cGMP, are the key molecules controlling mammalian oocyte 32 
meiosis. Their roles in oocyte biology have been at the forefront of oocyte research for decades and 33 
many of the long standing controversies in relation to the regulation of oocyte meiotic maturation 34 
are now resolved. It is now clear that the follicle prevents meiotic resumption through the actions of 35 
natriuretic peptides and cGMP inhibiting the hydrolysis of intra-oocyte cAMP and that the 36 
preovulatory gonadotrophin surge reverses these processes. The gonadotrophin surge also leads to a 37 
transient spike in cAMP in the somatic compartment of the follicle; research over the past 2 decades 38 
has conclusively demonstrated that this surge in cAMP is important for the subsequent 39 
developmental capacity of the oocyte. This is important, as oocyte in vitro maturation (IVM) 40 
systems practiced clinically do not recapitulate this cAMP surge in vitro, possibly accounting for 41 
the lower efficiency of IVM compared to clinical IVF.  This review focuses in particular on this 42 
latter aspect – the role of cAMP/cGMP in the regulation of oocyte quality.  We conclude that 43 
clinical practice of IVM should reflect this new understanding of the role of cyclic nucleotides, 44 





Oocyte maturation and oocyte quality are fundamental to fertility in all mammalian species. This is 50 
particularly evident in modern human infertility treatment where oocyte quantity and quality are 51 
rate-limiting to the success of nearly all artificial reproductive technologies (ART). We now know a 52 
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great deal about the regulation of oocyte maturation. It has long been recognised that one of the 53 
most important classes of molecules regulating mammalian oocyte maturation are the cyclic 54 
nucleotides; namely, cyclic adenosine 3’,5’-monophosphate (cAMP) and cyclic guanosine 3’,5’-55 
monophosphate (cGMP). These, in particular cAMP, have been the subject of intensive oocyte 56 
research for the past 40 years.  57 
 58 
The earliest report on the role of cAMP used a permeable cAMP, dibutyryl-cAMP (dbcAMP), 59 
demonstrating oocytes can be maintained in meiotic arrest in vitro after removal from their 60 
follicular environment (Cho et al. 1974). For the ensuing 20 years, cAMP and cGMP and their roles 61 
in the regulation of oocyte maturation were and remain intensively researched worldwide. This 62 
research focused largely on the regulation of meiosis; the role of the nucleotides in the maintenance 63 
of meiotic arrest and the resumption of meiosis, principally using rodents models (reviews from that 64 
period; (Dekel 1988, Eppig 1989)). This research area was complicated by the cAMP paradox, 65 
whereby high levels of oocyte cAMP maintain oocyte meiotic arrest, but at the time of ovulation, 66 
high follicular levels of cAMP induce meiotic resumption (Dekel et al. 1988). Understanding the 67 
mechanisms regulating oocyte meiotic resumption were further complicated by the controversy 68 
over the participation of falling cAMP levels and the simultaneous loss of cumulus-oocyte gap 69 
junctional communication (GJC). Many of the controversies of that period are now settled 70 
following landmark discoveries, including; the role of phosphodiesterases (PDEs) (Masciarelli et al. 71 
2004, Tsafriri et al. 1996), the sources and roles of cAMP (Mehlmann et al. 2002) and cGMP in the 72 
oocyte (Norris et al. 2009, Vaccari et al. 2009) and the participation of natriuretic peptides (Zhang 73 
et al. 2010).  74 
 75 
Hence today we have a thorough understanding of the participation of cAMP and cGMP in the 76 
regulation of mammalian oocyte meiosis. However, it is striking that the large numbers of studies 77 
from the 1970s-1990s, principally in mice, were largely limited to investigating oocyte meiosis and 78 
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did not follow the oocyte’s subsequent capacity to support embryo development, or oocyte 79 
developmental competence.  Curiously, even today, this central function of oocytes is not typically 80 
studied by mouse oocyte developmental biologists, but rather is the subject of major research efforts 81 
conducted by domestic animal oocyte biologists. It was first discovered in bovine and porcine 82 
oocytes that the spike of follicular cAMP that occurs at ovulation is important for the oocyte’s 83 
subsequent capacity to support embryo development (Aktas et al. 1995, Funahashi et al. 1997). 84 
This important discovery has led to a whole new area of research over the past 2 decades, which has 85 
shifted the focus of cyclic nucleotides away from oocyte meiosis towards oocyte developmental 86 
competence or oocyte quality, and how this is applied to improve outcomes in an ART context. 87 
 88 
1) Cyclic nucleotides and oocyte maturation in vivo 89 
 90 
1.1 Cyclic nucleotides maintain meiotic arrest  91 
 92 
1.1.1 The follicle maintains meiotic arrest 93 
A basic tenant of oocyte maturation is that oocytes in mid-sized antral and preovulatory follicles are 94 
competent to undergo oocyte meiotic maturation but are arrested at the germinal vesicle (GV) stage 95 
of meiosis by the follicle environment. Hence, oocytes removed from the follicle and placed in vitro 96 
will undergo hormone-independent, spontaneous meiotic maturation (Edwards 1965, Pincus and 97 
Enzmann 1935). It is the cyclic nucleotides, cAMP and cGMP, of follicular somatic and germ cell 98 
origin, that are the principal molecules responsible for maintaining oocyte meiotic arrest (see 99 
below).  100 
 101 
1.1.2 The follicle endows the oocyte with developmental competence  102 
During folliculogenesis, oocytes undergo changes at both the nuclear and cytoplasmic level that 103 
confer the oocyte with developmental competence, defined as the capacity to support 104 
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preimplantation embryo development (Gilchrist and Thompson 2007). Among other processes, 105 
changes in large-scale oocyte chromatin structure are essential for the onset of developmental 106 
competence (reviewed in (Luciano and Lodde 2013)). The proper maintenance of cumulus cell 107 
(CC)-oocyte gap-junctional communication (GJC) appears to have a crucial role in chromatin 108 
remodeling and the gradual transcription silencing processes that occur in fully grown oocytes, from 109 
early antral through to the latter half of antral folliculogenesis (De La Fuente and Eppig 2001, 110 
Lodde et al. 2008). CC-oocyte GJCs in turn are regulated by cyclic nucleotides, as FSH or a range 111 
of cAMP-modulating pharmaceuticals, sustain functional CC-oocyte communication (Atef et al. 112 
2005, El-Hayek and Clarke 2015, Luciano et al. 2004, Thomas et al. 2004a). In addition, treatment 113 
with FSH in vivo leads to oocyte chromatin condensation and suppress of transcription (De La 114 
Fuente and Eppig 2001, Zuccotti et al. 1998). The use of bovine cumulus-oocyte complex (COC) 115 
culture systems that prolong GJC, sustain oocyte growth and allow early chromatin compaction 116 
events are associated with the oocyte acquiring the ability to mature and be fertilized in vitro 117 
(Luciano et al. 2011).  However, when GJ functionality is experimentally interrupted, chromatin 118 
rapidly condenses and RNA synthesis abruptly ceases. Interestingly, this effect is nullified by 119 
preventing cAMP hydrolysis specifically within the oocyte (Luciano et al. 2011). Hence, since the 120 
preservation of an appropriate cAMP content in the oocyte, even in the absence of functional GJC, 121 
is able to prevent the abrupt condensation of chromatin, this suggests the cAMP cascade is the 122 
likely regulator of GJ-mediated actions on chromatin remodelling. These findings suggest that 123 
cAMP could be involved in the control of the activity of factors that modulate oocyte transcription 124 
and large-scale chromatin remodelling in fully grown oocytes during their final phase of 125 
development, immediately before the resumption of meiosis. 126 
 127 
1.1.3 cAMP control of meiotic arrest  128 
It has long been known that moderate to high intra-oocyte levels of the second messenger cAMP 129 
maintain oocyte meiotic arrest (Cho et al. 1974). Cyclic AMP is synthesized from ATP by an active 130 
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adenylyl cyclase (AC). In rodent oocytes, AC3 has been reported to be present and functional 131 
(Horner et al. 2003). GPR3 is a functional receptor found in the oocyte and hence the oocyte can 132 
independently synthesize cAMP (Mehlmann et al. 2002, Olsiewski and Beers 1983). However, a 133 
major source of intra-oocyte cAMP are the somatic cells surrounding the oocyte by virtue of the 134 
electrophysiological syncytium between the oocyte, cumulus and granulosa cells. Activation of CC 135 
ACs by FSH or forskolin loads the oocyte with many fold-increases in cAMP concentrations 136 
(Thomas et al. 2002). Sustained levels of intra-oocyte cAMP activates protein kinase A (PKA), 137 
which in turn prevents the activation of maturation promoting factor, retaining the oocyte in M-138 
phase. Cyclic nucleotide participation in the control of the meiotic cell cycle is reviewed elsewhere 139 
(Conti et al. 2012, Downs 2010). 140 
 141 
1.1.4 cGMP and phosphodiesterases  142 
The oocyte possesses a potent PDE that must be kept in check to maintain meiotic arrest. The study 143 
of oocyte PDEs began several decades ago, where it was found that non-specific PDE inhibitors, 144 
such as theophylline (Cho et al. 1974) and 3-isobutyl-1-methylxanthine (IBMX) (Dekel and Beers 145 
1978, Magnusson and Hillensjo 1977) maintain meiotic arrest of oocytes in vitro. Two studies 146 
published in the 1990’s reported the presence of a specific family of PDEs within the rodent oocyte, 147 
namely PDE3A; identified using in situ hybridization (Reinhardt et al. 1995) and sub-type specific 148 
PDE inhibitors such as milrinone and cilostamide (Tsafriri et al. 1996). Several years later, activity 149 
of the oocyte PDE3 was shown to increase prior to both spontaneous and gonadotrophin-induced 150 
meiotic resumption (Richard et al. 2001). The effect of specific PDE3 inhibitors on maintaining 151 
oocyte meiotic arrest in vitro has now been demonstrated across many mammalian species; rat 152 
(Tsafriri et al. 1996), mice (Wiersma et al. 1998), cattle (Mayes and Sirard 2002, Thomas et al. 153 
2002), monkeys (Jensen et al. 2002), human (Nogueira et al. 2003a) and swine (Laforest et al. 154 
2005). Demonstration of sterility of female mice bearing a PDE3A-null mutation due to the 155 
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ovulation of GV-stage oocytes was the final proof of the central role of PDE3A in maintaining 156 
oocyte meiotic arrest (Masciarelli et al. 2004). 157 
 158 
PDEs are organized into eleven families with the differing PDE isoenzymes capable of hydrolysing 159 
cAMP or cGMP or both nucleotides. An important finding was that PDE3A, which is the prominent 160 
PDE in the oocyte, is a cGMP-inhibited cAMP-hydrolysing enzyme (Maurice and Haslam 1990). It 161 
was long known that cGMP is an oocyte maturation inhibitor (Hubbard and Terranova 1982) and 162 
that ovarian levels of cGMP decline after LH stimulation (Ratner 1976). Three decades later the 163 
significance of this became apparent when two key papers revealed that it is cGMP permeating 164 
from the granulosa/CC compartment into the oocyte via gap-junctions that inhibits the oocyte’s 165 
PDE3A (Norris et al. 2009, Vaccari et al. 2009). Hence, cGMP from the follicular somatic cells 166 
maintains sufficient intra-oocyte cAMP to maintain the oocyte in meiotic arrest (Figure 1). 167 
 168 
1.1.5 Contribution of natriuretic peptides to meiotic arrest  169 
The signalling model for the maintenance of meiotic arrest has recently been enhanced by the 170 
finding of the important contribution of natriuretic peptides. The natriuretic peptide family is 171 
composed of three major types: atrial natriuretic peptide, brain natriuretic peptide and C-type 172 
natriuretic peptide (CNP). In an important study, it was shown that granulosa cells secrete CNP and 173 
CCs express its receptor, NPR2, which is a member of the guanylyl cyclase receptor family.  NPR2 174 
stimulation by CNP increased cGMP intracellular concentrations in both CCs and the oocyte and 175 
maintained meiotic arrest (Zhang et al. 2010). CNP has since been identified as an oocyte meiotic 176 
inhibiting peptide in a range of species in addition to mouse (Zhang et al. 2010); swine (Santiquet et 177 
al. 2014), cattle (Franciosi et al. 2014) and rats (Zhang et al. 2015). This knowledge now provides 178 
us with a logical model whereby the follicular compartment maintains oocyte meiotic arrest in vivo 179 
by supplying CNP-induced cGMP from the granulosa/CCs, via gap-junctions, to the oocyte to 180 
inhibit PDE3A, thereby maintaining sufficient cAMP to inhibit GV breakdown (GVBD; Figure 1). 181 




1.2 The ovulatory cascade:  183 
 184 
1.2.1 LH-induced changes in cyclic nucleotides 185 
The preovulatory surge of LH induces oocyte maturation, but neither oocytes nor CCs express LH 186 
receptors, so how does the LH surge lead to oocyte maturation? The exact cellular mechanisms and 187 
sequences of events that transduce the LH signal from the mural granulosa cells to the oocyte has 188 
been the topic of intense debate for decades. It is not the intention of this review to delve into these 189 
debates; fortunately, this is reviewed comprehensively elsewhere (Downs 2010). 190 
 191 
LH induces an acute transient spike in cAMP in the somatic compartment of the follicle. This is of 192 
the order of an 80- to 200-fold increase in cAMP, depending on the compartment measured (Albuz 193 
et al. 2010, Mattioli et al. 1994, Tsafriri et al. 1972, Yoshimura et al. 1992). The spike in cAMP 194 
appears in general to occur prior to GVBD, with levels falling sharply at around the time of GVBD. 195 
There is contradictory evidence as to whether the LH-induced spike in cAMP is transmitted into the 196 
oocyte (Norris et al. 2009, Yoshimura et al. 1992). This preovulatory spike in cAMP has meiotic 197 
inducing consequences, as cAMP pulsing of explanted follicles or isolated COCs in vitro induces 198 
the resumption of meiosis in the presence of inhibitory factors (Dekel et al. 1981, Downs et al. 199 
1988, Tsafriri et al. 1972). Hence, the acute changes in cAMP concentrations that follow the 200 
gonadotropin surge play a significant role in oocyte function, and this is an important point to note 201 
for cAMP-mediated oocyte in vitro maturation (IVM) systems (see Section 2 below). 202 
   203 
Despite this ovulatory pulse in follicular cAMP levels, activation of the oocyte PDE3A and a 204 
consequent fall in intra-oocyte cAMP is clearly a pre-requisite for de-phosphorylation of PKA, 205 
activation of maturation-promoting factor (MPF) and meiotic resumption (Figure 2). How is the 206 
rapid loss of oocyte cAMP achieved?  LH administration leads to a fall in follicular cGMP 207 
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(Hubbard 1986) and a loss of gap-junctions (Sela-Abramovich et al. 2005). The involvement of 208 
cGMP in the process of meiotic resumption was recently strengthened by the work of Shuhaibar et 209 
al. (Shuhaibar et al. 2015). Using follicles from mice expressing a FRET sensor, real-time 210 
monitoring of cGMP showed that within one minute of LH exposure, cGMP concentrations start to 211 
decrease from the peripheral granulosa cells and by 20 minutes the concentration of cGMP has 212 
decreased by more than 20-fold and was uniformly low across the follicle (Shuhaibar et al. 2015). 213 
Consequently, it is likely that oocyte cAMP concentration decreases because of relief of the 214 
inhibitory actions of cGMP on PDE3A in the oocyte (Norris et al. 2009, Vaccari et al. 2009).  215 
 216 
CNP activation of the NPR2 guanylyl cyclase is a principal source of cGMP in the follicle (Zhang 217 
et al. 2010), and LH down-regulates CNP transcript expression in mouse granulosa cells and CNP 218 
protein in follicular fluid (Kawamura et al. 2011). In human, an ovulatory dose of hCG results in a 219 
decrease in CNP levels in follicular fluid (Kawamura et al. 2011). LH induces a decrease in NPR2 220 
guanylyl cyclase activity within 20 minutes (Robinson et al. 2012) that can be explained by 221 
dephosphorylation and inactivation of NPR2 in granulosa cells (Egbert et al. 2014). Hence, a 222 
current model of oocyte meiotic resumption is that LH induces a spike in follicular cAMP and a 223 
simultaneous decline in CNP and cGMP, leading to activation of oocyte PDE3A causing a decline 224 
in intra-oocyte cAMP sufficient to activate MPF leading to meiotic resumption (Figure 2).  225 
 226 
1.2.2 The LH surge and cAMP spike activates the EGF network  227 
The cAMP spike within the mural granulosa cells initiates a signal transduction cascade which 228 
activates the EGF receptor-ERK1/2 pathway in order to induce oocyte maturation and ovulation. 229 
LH-induced cAMP production rapidly upregulates production of the EGF-like peptides (EGF-p) 230 
amphiregulin, epiregulin, and betacellulin to induce EGF receptor-ERK1/2 pathway signaling 231 
(Ashkenazi et al. 2005, Fan et al. 2009, Park et al. 2004, Shimada et al. 2006). Transcription of 232 
EGF-p is induced by cAMP activation of PKA, leading to the activation of the cAMP-response 233 
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element (CRE) site in the gene’s promoter region via a p38MAPK-CREB dependent process (Fan et 234 
al. 2009, Richards 2001, Shimada et al. 2006). Mature form EGF-p are cleaved from mural 235 
granulosa cells and bind to the EGF receptor (ERBB1), expressed on mural granulosa cells 236 
(autocrine) as well as on CCs (paracrine) (Hsieh et al. 2007, Yamashita et al. 2007). Ligand binding 237 
in both cell types leads to receptor dimerization and auto-phosphorylation on multiple tyrosine 238 
residues, which induce downstream RAS and, ultimately, ERK1/2 activation (Fan and Richards 239 
2010, Yamashita et al. 2007). ERK1/2 consequently promotes the production of prostaglandin E2 240 
by upregulating prostaglandin synthase 2 expression. Prostaglandin E2 then acts through the 241 
prostaglandin receptor PTGER2, expressed in both granulosa cell types, to induce further 242 
production of the EGF-p by activation of the cAMP-PKA-CREB pathway (Shimada et al. 2006), 243 
thus perpetuating the maturation-inducing stimulus in the LH-unresponsive CCs. Hence, LH-244 
induced upregulation of the cAMP-EGF-p-ERK1/2 signalling axis is involved in CC expansion, 245 
decreasing somatic cell cGMP, closure of GJs and possibly a meiotic-inducing stimulus of CC 246 
origin (Chen et al. 2013, Norris et al. 2010, Su et al. 2002).  247 
 248 
1.2.3 Loss of gap-junctions     249 
In the mammalian ovary, intercellular coupling between oocyte and CCs undergoes dynamic 250 
changes during follicle development (Anderson and Albertini 1976) and the patency of GJC 251 
between the oocyte and CC compartments decreases in parallel with the meiotic resumption of the 252 
oocyte (Eppig 1982, Larsen et al. 1986). In both in vivo and in IVM, the progressive disruption of 253 
GJC occurs concomitantly with the retraction and degeneration of CC transzonal projections (Hyttel 254 
et al. 1986). Whether this preovulatory loss of CC-oocyte GJC causes meiotic resumption, due to 255 
the termination of cAMP transfer from CCs to oocyte, as originally hypothesized (Dekel and Beers 256 
1978), has remained the subject of much debate for decades. Currently there appears to be strong 257 
evidence for the hypothesis that diffusion of cGMP from the oocyte to the somatic compartment 258 
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through functional GJs during GVBD has a crucial role in the reinitiation of meiosis (Norris et al. 259 
2009, Shuhaibar et al. 2015, Vaccari et al. 2009).  260 
 261 
2) Cyclic nucleotides and oocyte quality  262 
 263 
2.1 In vitro maturation (IVM)  264 
 265 
Advances in our understanding of the role of cyclic nucleotides in oocyte maturation have important 266 
practical applications in ART, in particular to oocyte IVM. IVM is an ART whereby COCs are 267 
collected at the immature GV stage from unstimulated or FSH-primed ovaries and matured as intact 268 
COCs in vitro prior to fertilisation (Edwards 1965). The most significant application of IVM is in 269 
the global production of livestock species, in particular cattle.  It is also conducted in other domestic 270 
species, including pig, sheep, goat, deer, cat, camels and horse, but to a much less extent compared 271 
with cattle breeding.  Global cattle embryo production by IVM/IVF exceeded 400,000 for the first 272 
time in 2013 (Perry 2014), with growth predicted to continue.  Nevertheless, this reported figure is 273 
likely to be grossly underestimated.  In this industry, immature oocytes are harvested from cows 274 
usually without exogenous hormone treatment, often on a regular basis (e.g. monthly) even during 275 
early pregnancy, which leads to a shortening of the intergenerational interval and genetic 276 
enrichment. In this industry, IVM is widely regarded as routine and safe. 277 
 278 
IVM has proved less successful in humans and its use and further development as a fertility 279 
treatment has been relatively limited compared to classical IVF following hormonal stimulation of 280 
ovaries. The principal reason for the poor uptake of human IVM appears to be its lower efficiency 281 
at generating pregnancies compared to conventional IVF, and not due to safety concerns (Buckett et 282 
al. 2007, Kuhtz et al. 2014, Spits et al. 2015) or other practical aspects of use of the technology. 283 
Women with polycystic ovaries (PCO) are excellent candidates for treatment with IVM, because of 284 
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their high number of antral follicles that can be aspirated for oocyte retrieval. In addition, these 285 
women have a particularly increased risk of ovarian hyperstimulation syndrome, a potentially life-286 
threatening iatrogenic complication of gonadotrophin stimulation, which has never been reported 287 
after IVM treatment. Currently, IVM is principally used for women with PCO. However, an 288 
important new application of IVM is for fertility preservation for young women who are diagnosed 289 
with cancer and face a substantial risk of gonadotoxicity secondary to chemotherapy or 290 
radiotherapy. For these women, for whom time is usually pressing, IVM is advantageous as it is 291 
possible to harvest oocytes at short notice without prior hormone therapy, and without elevated 292 
oestrogen levels which is contraindicated in cases of hormone sensitive tumors (De Vos et al. 293 
2014). 294 
 295 
In the context of modern milder approaches to ART, the increasing demand from patients for a 296 
simpler, cheaper, more patient friendly reproductive technology, the search for improvements in 297 
IVM are continuing and improved pregnancy rates have recently been established by a number of 298 
centers (Junk and Yeap 2012, Ortega-Hrepich et al. 2013, Walls et al. 2015a). Nonetheless, the 299 
reduced pregnancy rates per started cycle compared with conventional IVF, at least in the majority 300 
of centers where IVM is applied, represents a major obstacle that needs to be overcome for 301 
widespread uptake of IVM.  This lower efficiency manifests at multiple levels: particularly lower 302 
metaphase II rates (typically 50-60%), but also lower subsequent embryo development rates (Walls 303 
et al. 2015b), and at least in the past, higher miscarriage rates.  The application of cAMP-304 
modulators to IVM offers great promise to improve IVM pregnancy rates. More than 10 years of 305 
animal data using a range of cAMP-modulated IVM systems, together provide compelling evidence 306 
that IVM efficiency and pregnancy outcomes can be substantially improved by carefully controlling 307 
cAMP levels during IVM.  308 
 309 
2.2 Cyclic AMP-mediated IVM Systems 310 




The following section reviews the various oocyte IVM systems/technologies, as pertaining to IVM 312 
regulated by the cyclic nucleotides. The modes of actions of some of the pharmacological agents 313 
used to manipulate cyclic nucleotides in IVM are listed in Table 1. For ease of discussion, the IVM 314 
systems are broadly divided into four IVM approaches (Figure 3), although we recognise that there 315 
is overlap between them. Whilst Standard IVM remains the approach used almost universally in 316 
human and veterinary clinical practice, the other three approaches can be considered to be at the 317 
pre-clinical stage of development, with substantial evidence of benefit accumulated (Table 2). The 318 
basic rationale for moving beyond Standard IVM is that oocyte maturation does not naturally occur 319 
“spontaneously” in vivo, but rather is an induced process that occurs in response to a rapid and 320 
transient surge in somatic/COC cAMP (Dekel and Beers 1978).   321 
 322 
2.2.1 Standard IVM (low cAMP): 323 
Standard IVM refers to the isolation of immature COCs from antral follicles and their subsequent 324 
maturation in medium lacking cAMP modulating agents (Figure 3A).  This method is based on the 325 
original principals of spontaneous oocyte meiotic maturation as described many decades ago 326 
(Edwards 1965, Pincus and Enzmann 1935). Standard IVM systems typically contain FSH or other 327 
additives such as EGF, EGF-p and/or LH/hCG (Figure 3A). FSH leads to a transient rise in COC 328 
cAMP (Li et al. 2012) (Figure 3E), but if COC collection and processing is slow (see 2.2.5) or if 329 
FSH is omitted from IVM, then cAMP levels fall rapidly causing spontaneous meiotic resumption 330 
(Aktas et al. 1995, Luciano et al. 2004). In some species, FSH has negligible effects on MII rates 331 
and oocytes mature spontaneously (e.g. murine, bovine, ovine), whereas in others FSH significantly 332 
improves MII rates suggesting an element of meiotic induction (e.g. porcine, human). As cAMP 333 
hydrolysis is permitted in this system, intra-oocyte cAMP levels fall (Figure 3E), leading to 334 
inactivation of PKA and rapid progression to GVBD (Li et al. 2012, Norris et al. 2009, Vaccari et 335 
al. 2009).  336 




2.2.2 Biphasic-IVM (moderate cAMP):   338 
Biphasic IVM systems use a relatively high concentration of a PDE inhibitor to prevent 339 
spontaneous GVBD of COCs upon removal from the follicle for an extended period (e.g. 24 hours 340 
or more; Figure 3B), thereby preserving the moderate cAMP levels stimulated by FSH (Figure 3E) 341 
(Kawashima et al. 2008, Nogueira et al. 2003b, Nogueira et al. 2006).  Examples of PDEs used 342 
include: Org9935, cilostamide, milrinone, IBMX, and CNP (Table 2). Then in the second IVM 343 
phase the inhibitor is washed out allowing cAMP levels to fall and oocyte maturation to proceed 344 
(Figure 3B). In general, biphasic IVM systems have been shown to lead to modest improvements in 345 
oocyte developmental competence, relative to standard IVM (see Table 2 for references).  346 
 347 
2.2.3 Induced IVM (moderate cAMP): 348 
For oocytes that are naturally GV-arrested (e.g. intra-follicular) or artificially GV-arrested (e.g. 349 
isolated COCs arrested using a PDE inhibitor), meiosis can be readily induced using natural ligands 350 
such as FSH, EGF and EGF-p (Dekel and Beers 1978, Dekel and Sherizly 1985, Downs et al. 351 
1988). Oocyte maturation is “induced” as meiotic maturation is inhibited in the absence of such 352 
meiotic stimulating ligands, and the actions of these ligands are mediated by CCs as they induce 353 
GVBD in intact explanted follicles or in COCs in vitro, but importantly not in DOs in vitro (Downs 354 
et al. 1988, Park et al. 2004). Hence, Induced IVM systems typically incorporate the simultaneous 355 
application of a meiotic inhibitor and a meiotic inducing ligand (Figure 3C) (Thomas et al. 2004b). 356 
GVBD and progression to MII occurs in the presence of the meiotic inhibitor, at moderate-low 357 
levels of COC cAMP (Figure 3E).  This system, as pioneered by Downs and Eppig (Downs et al. 358 
1988), has been used extensively for decades as a mouse oocyte experimental model to study the 359 
cellular and molecular control of meiotic induction (Downs 2010), but curiously has not been 360 
examined in detail in oocyte developmental competence studies (see Table 2 for references).  361 
 362 
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2.2.4 Induced IVM (high cAMP): 363 
The distinguishing feature of this approach to IVM is the inclusion of pharmacological agent(s) that 364 
increase COC cAMP or induce the synthesis of large quantities of cAMP in the COC (Figure 3D). 365 
This approach was pioneered by Funahashi H. et al by treating porcine COCs with dbcAMP leading 366 
to improved subsequent blastocyst yield (Funahashi et al. 1997). Using dbcAMP has since proved 367 
highly successful and is now in widespread use in porcine IVM embryo production systems (Table 368 
2).  Other cAMP-elevating agents of note used for this approach include invasive adenylate cyclase 369 
(iAC; (Aktas et al. 1995, Luciano et al. 1999)) and forskolin (Ali and Sirard 2005, Shu et al. 2008). 370 
Forskolin in particular, leads to rapid and large increases in whole COC and intra-oocyte cAMP 371 
(Bernal-Ulloa et al. 2016, Thomas et al. 2002); to levels that approximate the spike in COC cAMP 372 
levels that occurs in vivo in response to LH (Figure 3E) (Wang et al. 2011). As such, one such 373 
approach has been named simulated physiological oocyte maturation (SPOM; (Albuz et al. 2010, 374 
Gilchrist et al. 2015)). The COC cAMP profile in response to these pharmacological agents is 375 
usually more acute and notably higher than that achieved by FSH treatment of COCs, as per 376 
Standard IVM (Albuz et al. 2010). Such Induced IVM systems typically incorporate a pre-IVM 377 
(Luciano et al. 1999) or biphasic approach (Funahashi et al. 1997) (Figure 3D), whereby COCs are 378 
exposed to the cAMP-elevating agent for several hours (e.g. 2h; pre-IVM) to up to 22-24h 379 
(biphasic). This is then usually followed by an IVM phase lacking pharmacological AC activators, 380 
either in the presence (Zeng et al. 2013) or absence of FSH (Sugimura et al. 2015). A PDE inhibitor 381 
such as cilostamide can be included in the IVM phase, as used in SPOM version 1 (Albuz et al. 382 
2010), or omitted as per SPOM version 2 ((Gilchrist et al. 2015, Li et al. 2016, Richani et al. 383 
2014b, Zeng et al. 2013, Zeng et al. 2014)) and in the iAC and dbcAMP approaches (Funahashi et 384 
al. 1997, Guixue et al. 2001, Luciano et al. 1999).  385 
 386 
It is noteworthy that in all Induced IVM (high cAMP) approaches, oocyte meiotic maturation is 387 
induced as a result of the elevated CC cAMP, even in the presence of a PDE inhibitor (Dekel et al. 388 
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1988, Shu et al. 2008) (N.B. this does not or is less likely to occur in Biphasic IVM). This may 389 
seem paradoxical, as pharmacological stimulation of cAMP synthesis in CCs increases intra-oocyte 390 
cAMP by at least an order of magnitude (Thomas et al. 2002), initially preventing GVBD. But in 391 
fact this cAMP surge induces CC synthesis of potent meiotic inducing factors (e.g. EGF-p, (Richani 392 
et al. 2014b); see section 2.3.5), that may recapitulate at least some of the meiotic inducing events 393 
that occur during oocyte maturation in vivo. It is interesting that in Induced IVM systems, GVBD 394 
occurs at a higher intra-oocyte cAMP concentration than in Standard IVM (Wang et al. 2011). 395 
However, despite the clear improvements across species in oocyte developmental competence using 396 
Induced IVM systems (Table 2), this mode of oocyte maturation does not necessarily led to clear 397 
improvements in MII rates, which would be useful in species such as human where IVM MII rates 398 
are typically low (~50%) (Shu et al. 2008, Zeng et al. 2013). 399 
 400 
2.2.5 The oocyte collection phase: 401 
COC collection conditions and the ensuing first hour are paramount to IVM success. A large part of 402 
the developmental competence that the oocyte has acquired in the follicle can be lost in this first 403 
hour. It is important that during this period; 1) the oocyte receives key nutrient support (Frank et al. 404 
2013), and 2) that activation of the oocyte’s potent PDE is prevented. Therefore, cAMP-mediated 405 
IVM systems require a PDE inhibitor in the oocyte collection medium, otherwise upon isolation of 406 
the COC, the loss of follicular cGMP will lead to rapid activation of the oocyte’s PDE, loss of 407 
cAMP (Aktas et al. 1995, Albuz et al. 2010, Luciano et al. 2004), de-activation of PKA, loss of 408 
CC-oocyte gap junctions, cessation of oocyte transcription and irreversible resumption of meiosis 409 
(Li et al. 2012, Luciano et al. 2011). It is noteworthy that in the enormous body of IVM literature 410 
using porcine and bovine abattoir-sourced oocytes, these COCs are invariably collected and 411 
processed in undiluted or high concentration follicular fluid, which serves the two purposes of COC 412 
nutrient provision and PDE inhibition. Therefore, the clinical practice of performing IVM oocyte 413 
pick-ups with saline, PBS or simple holding medium is likely to be particularly detrimental to 414 
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oocyte quality. We have recently demonstrated that the inclusion of IBMX in human oocyte 415 
collection medium supports subsequent oocyte maturation and healthy embryo development (Spits 416 
et al. 2015). 417 
 418 
2.2.6 Cyclic AMP-mediated IVM and oocyte developmental competence: 419 
The number of publications accumulated over the past decade now provides compelling evidence 420 
that cAMP-mediated IVM systems can lead to notably improved oocyte quality, compared to 421 
Standard IVM, as measured by enhanced subsequent pre-implantation embryo development and 422 
quality (see table 2 for citation list). Hence these novel approaches to IVM are now highly attractive 423 
for clinical and commercial applications, to bridge the efficiency gap between IVM and IVF.  The 424 
different cAMP-mediated IVM systems yield differing outcomes. In general terms, biphasic IVM 425 
and Induced IVM (low cAMP) approaches led to only modest improvements in blastocyst yield, 426 
whereas Induced IVM systems producing high COC cAMP levels generally lead to larger 427 
improvements in oocyte quality (Figure 3, Table 2). Induced IVM systems lead to apparently 428 
healthy pregnancies and offspring (Akaki et al. 2009, Albuz et al. 2010, Bernal-Ulloa et al. 2016). 429 
There remain challenges however in working with these systems (Gilchrist et al. 2015). Firstly, 430 
manipulating oocyte cAMP has major effects on oocyte meiotic kinetics, and hence timing to MII 431 
should be assessed carefully under local laboratory conditions (see 2.3.4). Secondly, IVM systems, 432 
where CC and oocyte functions are acutely altered, such as SPOM version 1, can be difficult to 433 
work with practically and strict attention to protocol is needed (Gilchrist et al. 2015). This led us to 434 
develop a more user-friendly SPOM version 2 (Zeng et al. 2013, Zeng et al. 2014). These issues 435 
highlight that, to realise the full potential of these novel approaches to IVM, further refinement of 436 
practical aspects of IVM protocols is warranted. 437 
 438 
2.3  Impact of cAMP-mediated IVM on CCs and the oocyte 439 
 440 
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Since there is a clear beneficial effect of cAMP-mediated IVM systems on oocyte developmental 441 
competence (Table 2), the effect of cAMP-mediated IVM on cellular and molecular aspects of CC 442 
and oocyte function are of interest as a means to: 1) provide insights into basic mechanisms 443 
regulating oocyte quality, and 2) offer opportunities to further improve IVM efficiency.  444 
 445 
2.3.1 CC microarray analysis  446 
Recent microarray analysis of CCs after 6 hour exposure to cAMP-elevating agents (forskolin + 447 
IBMX + dipyridamole; see Table 1) was undertaken to elucidate cAMP-induced gene networks 448 
(Khan et al. 2015). These culture conditions were previously demonstrated to give higher yield of 449 
embryo development (Ali and Sirard 2005).  The study demonstrated that cAMP significantly and 450 
specifically modulated gene expression dynamics including genes involved in cell metabolism, cell 451 
communication, signal transduction, steroidogenesis, cell survival and extracellular matrix 452 
formation (Khan et al. 2015). Genes involved in cell metabolism such as GFPT2 (glutamine-453 
fructose-6-phosphate transaminase 2) and HK2 (hexokinase 2) were significantly up-regulated by 454 
the cAMP-elevating agents, as well as genes involved in carbohydrate uptake (SLC2A1, solute 455 
carrier family 2 - facilitated glucose transporter, members 1 and 3, respectively) and steroidogenesis 456 
(STAR, steroidogenic acute regulatory protein). Interestingly, down-regulation of EGF pathway 457 
genes (AREG, amphiregulin and HAS2, hyaluronan synthase 2), which are involved in cumulus 458 
expansion were observed ((Khan et al. 2015); see end of section 2.3.5 for temporal effects). 459 
Decreased phosphorylation of ERK1/2 supports a possible negative regulatory role of PKA in this 460 
process. These findings imply that treatment of COCs with cAMP-elevating agents up-regulate 461 
genes in cell metabolism, carbohydrate uptake and steroidogenesis and down-regulate genes of the 462 
EGF pathway (Khan et al. 2015).  463 
 464 
2.3.2 CC-oocyte gap-junctional communication   465 
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A central objective of most modern IVM systems is to preserve CC-oocyte communication as it is 466 
viewed as critical to generating a healthy mature oocyte capable of sustaining embryo development 467 
(Gilchrist 2011). Under standard IVM conditions, the drop in COC cAMP concentration that occurs 468 
soon after removal of the COC from the antral follicle (Aktas et al. 1995, Albuz et al. 2010) is 469 
accompanied by initiation of closure of CC-oocyte GJs (Thomas et al. 2004a). This loss of GJC is 470 
attenuated to some extent by the inclusion of FSH in standard IVM media (Atef et al. 2005). FSH 471 
stimulates expression of genes encoding connexins including Gja1 (El-Hayek and Clarke 2015), 472 
possibly via a PKA-regulated mechanism (Yun et al. 2012).  Inhibiting COC cAMP hydrolysis, in 473 
either the CC or oocyte compartment using selective PDE inhibitors, further attenuates the loss of 474 
GJC and is usually associated with a delay in GVBD (Luciano et al. 2004, Thomas et al. 2004a). 475 
By contrast, using cAMP elevating agents in IVM, such as forskolin or dbcAMP, not only prevent 476 
GJC loss but maintain full patency for extended periods of IVM (Albuz et al. 2010, Li et al. 2016, 477 
Shu et al. 2008, Thomas et al. 2004a). Using cAMP-mediated approaches to preserve CC-oocyte 478 
GJCs in IVM is nearly always associated with an improvement in subsequent oocyte developmental 479 
competence (see Table 2 for citations). Furthermore, blocking GJs negates any benefits of cAMP-480 
mediated IVM in terms of subsequent embryo development (Atef et al. 2005). The molecular 481 
mechanisms underlying the improvement in oocyte quality are less clear; GJ-mediated effects on 482 
oocyte metabolism may be important (see 2.3.6), as well as effects on oocyte transcription. As 483 
outlined in section 2.1.2, addition of cAMP modulators to IVM prevents premature chromatin 484 
condensation and permits continued oocyte RNA synthesis, and it has been hypothesized that this 485 
occurs via a GJ-mediated mechanism (De La Fuente and Eppig 2001, Luciano et al. 2011). 486 
 487 
2.3.4 Kinetics of meiosis  488 
A founding principal of cAMP-mediated IVM systems is to prevent spontaneous GVBD of oocytes 489 
upon removal from antral follicles (Gilchrist and Thompson 2007), and as such the kinetics of the 490 
meiotic cell cycle are notably different in these cAMP-mediated oocyte maturation systems (Figure 491 
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3). GVBD occurs most rapidly under spontaneous IVM (e.g. mouse, ~1 hour; bovine, ~ 6 hours) 492 
where there is uncontrolled loss of intra-oocyte cAMP leading to the activation of MPF. Using bi-493 
phasic IVM systems, GVBD is prevented for as long as a cAMP modulator is present; typically 22-494 
48h (Nogueira et al. 2003b, Nogueira et al. 2006). In Induced IVM systems, GVBD is typically 495 
delayed (but not inhibited) by several hours, for example; from 1-3 h in the mouse, or from 6-7 h to 496 
10-12 h in bovine (Albuz et al. 2010, Thomas et al. 2004a)). Whether time to MII is delayed 497 
depends on the type, dose and combination of cAMP modulators used, but commonly MII is either 498 
not delayed (Kim et al. 2008) or delayed by only several hours (Albuz et al. 2010, Rose et al. 2013, 499 
Thomas et al. 2004b). However, as GVBD is always delayed, this means that usually the GVBD to 500 
MII interval is commonly shortened using Induced or Biphasic IVM systems, relative to Standard 501 
IVM (Kim et al. 2008, Thomas et al. 2004b). There is strong evidence that this occurs because 502 
these IVM systems generate potent meiotic-inducing factors, likely of CC origin requiring EGFR 503 
signalling [see next; (Albuz et al. 2010, Dekel et al. 1988, Downs and Chen 2008)]. The net effect 504 
of this rapid progression through meiosis is a reduction in meiotic asynchrony, as originally 505 
identified by Funahashi et al (1997); i.e. a reduction in the range of times at which a cohort of 506 
oocytes reach MII. Hence, a significant benefit of cAMP-mediated IVM systems is likely to be a 507 
reduction in in vitro ageing of IVM oocytes, which may account for their improved subsequent 508 
developmental competence.    509 
 510 
2.3.5 CC EGF signalling 511 
The effect of cAMP elevation in CCs in induced IVM systems (e.g. SPOM; Fig 3D) is mediated, at 512 
least in part, by EGF receptor activity. The EGF receptor inhibitor AG1478 blocks GVBD in COCs 513 
pulsed with dbcAMP to stimulate maturation (Downs and Chen 2008). The same effect is also 514 
observed in SPOM COCs exposed to AG1478 (Albuz et al. 2010). Moreover, recent genetic 515 
dissection of the effect of elevated cAMP in vitro implicates PKA and ERK1/2 pathways, which are 516 
interconnected with EGF receptor signaling, as key downstream signalling regulators of cAMP in 517 
Page 20 of 50
21 
 
vitro (Khan et al. 2015). The increased developmental competence of cAMP-mediated IVM oocytes 518 
may in part be attributable to the impact of cAMP on EGF pathway signaling in CCs. Standard 519 
IVM conditions (including with FSH) exhibit perturbed CC expression of EGF-p relative to those 520 
matured in vivo (Richani et al. 2013), leading to alterations in COC glucose metabolism and 521 
decreased oocyte mitochondrial activity (Richani et al. 2014a). Cyclic AMP elevation using 522 
forskolin leads to a large, but very transient, increased expression of CC amphiregulin, epiregulin, 523 
and betacellulin, compared to unstimulated or IBMX-treated COCs (Richani et al. 2014b). 524 
However, the large increase in EGF-like peptide expression does not translate into increased 525 
activation of the EGF receptor or its downstream target ERK1/2 (Richani et al. 2014b), suggesting 526 
that the cAMP-induced spike in EGF-like peptides may impact alternate downstream EGF receptor 527 
targets (Chen et al. 2013), or may alter temporal EGFR signaling through negative feedback. The 528 
latter hypothesis is supported by evidence showing increased EGF-p expression after 2 hours of 529 
forskolin exposure in the mouse, but not at 4h (mouse) or 6h (cow) (Khan et al. 2015, Richani et al. 530 
2014b).  531 
 532 
2.3.6 COC metabolism and oocyte antioxidant defence    533 
There appears to be an effect of cAMP-mediated IVM on CC and oocyte metabolism, consistent 534 
with the established relationship between oocyte developmental competency and oocyte metabolism 535 
(Thompson et al. 2007). The basic pattern of metabolism during development and maturation of the 536 
oocyte is demonstrated as a dynamic process with the consumption of oxygen and the utilisation of 537 
nutrients present in culture media; mainly glucose, pyruvate and lactate (Leese 2015). Induced-IVM 538 
(high cAMP; SPOMv2; Figure 3D) systems that enhance oocyte quality, lead to increased lactate 539 
production by COCs over the course of IVM, suggesting stimulation of CC glycolysis (Zeng et al. 540 
2014). Significantly, treating COCs during pre-IVM with forskolin plus IBMX leads to intra-oocyte 541 
GSH accumulation in a pre-IVM duration-dependent manner, which is ablated when GJs are 542 
blocked (Li et al. 2016, Zeng et al. 2014). This cAMP-mediated increase in GSH is associated with 543 
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lower levels of H2O2, suggesting that a key benefit of cAMP-mediated IVM may be an 544 
improvement in the oocyte’s antioxidant defenses requiring GSH supplied by CCs (Li et al. 2016). 545 
As increased GSH levels are highly correlated with oocyte developmental competence (de Matos et 546 
al. 1995) this may at least partly explain why pre-maturation with these agents improves oocyte 547 
competence. Cyclic AMP-modulated pre-IVM treatments also increase COC oxygen consumption 548 
and oocyte oxidative metabolism, associated with an increase in the oocyte redox ratio and a higher 549 
ATP:ADP ratio (Zeng et al. 2013, Zeng et al. 2014). Therefore, activation of cAMP signalling 550 
pathways during oocyte maturation not only impacts on oocyte metabolism but also on oocyte 551 
antioxidant defense, in a GJ-dependent manner (Li et al. 2016). 552 
 553 
Conclusions     554 
 555 
The scientific and medical community now have at hand a vast body of literature on the role of 556 
cyclic nucleotides in mammalian oocyte function. Their role in the regulation of oocyte meiosis is 557 
now clear and more recently, we have acquired substantial experimental evidence that the delicate 558 
balance of cyclic nucleotides between the somatic and germ cell compartments plays a key role in 559 
oocyte developmental competence. Current research is directed to understanding the possible 560 
mechanisms by which cyclic nucleotides improve oocyte quality (Figure 4). Nonetheless, it is clear 561 
that application of cAMP modulators in IVM can present practical challenges, for example, on the 562 
timing of meiosis, and may present regulatory issues. The challenge therefore to the medical and 563 
veterinary disciplines is to capitalise on these new scientific and technological advances to improve 564 
the efficacy of IVM, for the benefit of infertile and cancer patients and for domestic animal 565 
breeding.  566 
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Figure 1: The coordination between CNP, cGMP and cAMP in the control of oocyte meiotic 
arrest. See text for abbreviations. 
 
Figure 2: The cyclic nucleotides transmit the ovulatory cascade from the somatic to 
germ cell compartment of the follicle, instructing the oocyte to resume meiosis in 
preparation for ovulation. See text for abbreviations. 
 
Figure 3:  Differing approaches to cAMP-mediated IVM.  
Schematic comparison of Standard IVM containing FSH but no cAMP modulating agents (A), to 
various cAMP-mediated IVM systems, including; (B) Biphasic IVM using a PDE inhibitor for the 
first phase followed by wash-out and PDE inhibitor free in the second phase, (C) Induced IVM 
producing moderate cAMP levels, where oocytes are matured in the simultaneous presence of PDE 
inhibitor and an inducing ligand, and (D) Induced IVM where exogenous cAMP or AC activators 
produce high levels of COC cAMP. (E) Schematic illustration of actual and predicted COC cAMP 
levels in the differing IVM systems containing FSH, compared to Standard IVM and in oocytes 
matured in vivo. In the absence of FSH in Standard IVM, COC cAMP levels fall rather than rise 
(modified from (Thompson and Gilchrist 2013)). GV, germinal vesicle; GVB, germinal vesicle 
breakdown; MII, metaphase II; EGF-p, epidermal growth factor-like peptides; PDE, 
phosphodiesterase. 
 
Figure 4: Possible mechanisms by which high levels of COC cAMP during in vivo oocyte 
maturation or by Induced-IVM improve oocyte quality.  GJC, gap-junctional communication; 
GSH, glutathione; ROS, reactive oxygen species; EGF-p, epidermal growth factor-like peptides; 
GVBD, germinal vesicle breakdown.  




Table 1: Pharmacological agents used in IVM to manipulate cyclic nucleotides. 
 
 
Agent Mode of Action Remarks 
Hypoxanthine, IBMX PDE inhibitors: broad spectrum Act on CC and oocyte PDEs to 
prevent cAMP hydrolysis  
Org9935, cilostamide, 
milrinone 
PDE3-specific inhibitors Target the PDE in the oocyte 
(PDE3A) to prevent intra-oocyte 
cAMP hydrolysis  
Rolipram PDE4-specific inhibitor Target the PDE in CC and MGC 
(PDE4) to prevent cAMP 
hydrolysis 
Dipyridamole PDE8-specific inhibitor Inhibits PDE8 in CCs (bovine) 
to prevent cAMP hydrolysis 
CNP NPR2 agonist Stimulates CC and MGC cGMP 
synthesis thereby antagonising 
PDE 
Sildenafil PDE5 and PDE6 inhibitor Target CC and MGC PDEs to 
prevent cGMP hydrolysis 
Forskolin, iAC AC activators Elevate CC/oocyte cAMP 
dbcAMP, 8-bromo-cAMP cAMP analogous Elevate CC/oocyte cAMP 
Abbreviations: IBMX, 3-isobutyl-1-methylxanthine; PDE, phosphodiesterase; CC, cumulus cell; 
MGC, mural granulosa cell; CNP, C-type natriuretic peptide; NPR2, natriuretic peptide receptor 2; 




Page 40 of 50
41 
 
Table 2: Effect of cAMP-mediated IVM on subsequent oocyte developmental competence 
IVM system cAMP 
modulator 






Org 9935 Human None (Nogueira et al. 2006) 
Murine Improved (Nogueira et al. 2003b)  
Cilostamide Human None (Vanhoutte et al. 2007) 
Human Improved (Vanhoutte et al. 2009a, Vanhoutte et al. 2009b) 
Bovine Improved (Luciano et al. 2011) 
Porcine Improved (Dieci et al. 2013) 
 IBMX Bovine Improved (Lodde et al. 2013) 
  Porcine Improved (Kawashima et al. 2008) 







(Thomas et al. 2004b) 
(Grupen et al. 2006) 
Rolipram Bovine Improved (Thomas et al. 2004b) 
Dipyridamole Bovine Decreased (Sasseville et al. 2009) 
Hypoxanthine Murine None (Downs et al. 1986) 
Induced IVM 
(high cAMP) 
dbcAMP Porcine Improved (Akaki et al. 2009, Bagg et al. 2006, Funahashi et al. 1997, Kim et al. 2008, 
Nascimento et al. 2010, Somfai et al. 2003, Sugimura et al. 2015) 
  None (Appeltant et al. 2015, Park and Yu 2013) 
iAC Bovine Improved (Guixue et al. 2001, Luciano et al. 2004, Luciano et al. 1999) 
 Bovine None (Aktas et al. 1995) 
Forskolin Human Improved (Shu et al. 2008) 
Murine Improved (Albuz et al. 2010, Richani et al. 2014b, Zeng et al. 2013, Zeng et al. 2014) 
Bovine Improved (Albuz et al. 2010, Ali and Sirard 2005, Li et al. 2016) 
Bovine None/Decreased (Bernal-Ulloa et al. 2016, Guimaraes et al. 2015, Ulloa et al. 2014) 
Ovine Improved (Rose et al. 2013) 
Ovine None (Buell et al. 2015) 
* Relative to standard IVM control. As assessed by embryo development typically to the blastocyst stage.  
Abbreviations: IBMX, 3-isobutyl-1-methylxanthine; CNP, C-type natriuretic peptide; iAC, invasive adenylate cyclase; dbcAMP, dibutyryl cAMP. 
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Figure Legends: 
 
Figure 1: The coordination between CNP, cGMP and cAMP in the control of oocyte 
meiotic arrest. See text for abbreviations. 
 
Figure 2: The cyclic nucleotides transmit the ovulatory cascade from the 
somatic to germ cell compartment of the follicle, instructing the oocyte to 
resume meiosis in preparation for ovulation. See text for abbreviations. 
 
Figure 3:  Differing approaches to cAMP-mediated IVM.  
Schematic comparison of Standard IVM containing FSH but no cAMP modulating agents 
(A), to various cAMP-mediated IVM systems, including; (B) Biphasic IVM using a PDE 
inhibitor for the first phase followed by wash-out and PDE inhibitor free in the second phase, 
(C) Induced IVM producing moderate cAMP levels, where oocytes are matured in the 
simultaneous presence of PDE inhibitor and an inducing ligand, and (D) Induced IVM where 
exogenous cAMP or AC activators produce high levels of COC cAMP. (E) Schematic 
illustration of actual and predicted COC cAMP levels in the differing IVM systems 
containing FSH, compared to Standard IVM and in oocytes matured in vivo. In the absence of 
FSH in Standard IVM, COC cAMP levels fall rather than rise (modified from (Thompson 
and Gilchrist 2013)). GV, germinal vesicle; GVB, germinal vesicle breakdown; MII, 
metaphase II; EGF-p, epidermal growth factor-like peptides; PDE, phosphodiesterase. 
 
Figure 4: Possible mechanisms by which high levels of COC cAMP during in vivo oocyte 
maturation or by Induced-IVM improve oocyte quality.  GJC, gap-junctional 
communication; GSH, glutathione; ROS, reactive oxygen species; EGF-p, epidermal growth 
factor-like peptides; GVBD, germinal vesicle breakdown. 








































Page 45 of 50
A.   Standard IVM 
C.   Induced IVM (moderate cAMP)   
B.   Biphasic IVM 
+ 
GV GVB MII 


























• preservation of GJC 
•  glycolysis,  oxidative metabolism 
•  GSH    ROS 
• activation of EGF-p cascade 
• ordered cessation of RNA synthesis 
• delayed GVBD 
•  meiotic asynchrony 
 Embryo 
Development 
 Fetal Viability 
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Table 1: Pharmacological agents used in IVM to manipulate cyclic nucleotides. 
 
 
Agent Mode of Action Remarks 
Hypoxanthine, IBMX PDE inhibitors: broad spectrum Act on CC and oocyte PDEs to 
prevent cAMP hydrolysis  
Org9935, cilostamide, 
milrinone 
PDE3-specific inhibitors Target the PDE in the oocyte 
(PDE3A) to prevent intra-oocyte 
cAMP hydrolysis  
Rolipram PDE4-specific inhibitor Target the PDE in CC and MGC 
(PDE4) to prevent cAMP 
hydrolysis 
Dipyridamole PDE8-specific inhibitor Inhibits PDE8 in CCs (bovine) 
to prevent cAMP hydrolysis 
CNP NPR2 agonist Stimulates CC and MGC cGMP 
synthesis thereby antagonising 
PDE 
Sildenafil PDE5 and PDE6 inhibitor Target CC and MGC PDEs to 
prevent cGMP hydrolysis 
Forskolin, iAC AC activators Elevate CC/oocyte cAMP 
dbcAMP, 8-bromo-cAMP cAMP analogous Elevate CC/oocyte cAMP 
Abbreviations: IBMX, 3-isobutyl-1-methylxanthine; PDE, phosphodiesterase; CC, cumulus 
cell; MGC, mural granulosa cell; CNP, C-type natriuretic peptide; NPR2, natriuretic peptide 
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Table 2: Effect of cAMP-mediated IVM on subsequent oocyte developmental competence 
IVM system cAMP 
modulator 






Org 9935 Human None (Nogueira et al. 2006) 
Murine Improved (Nogueira et al. 2003b)  
Cilostamide Human None (Vanhoutte et al. 2007) 
Human Improved (Vanhoutte et al. 2009a, Vanhoutte et al. 2009b) 
Bovine Improved (Luciano et al. 2011) 
Porcine Improved (Dieci et al. 2013) 
 IBMX Bovine Improved (Lodde et al. 2013) 
  Porcine Improved (Kawashima et al. 2008) 







(Thomas et al. 2004b) 
(Grupen et al. 2006) 
Rolipram Bovine Improved (Thomas et al. 2004b) 
Dipyridamole Bovine Decreased (Sasseville et al. 2009) 
Hypoxanthine Murine None (Downs et al. 1986) 
Induced IVM 
(high cAMP) 
dbcAMP Porcine Improved (Akaki et al. 2009, Bagg et al. 2006, Funahashi et al. 1997, Kim et al. 2008, 
Nascimento et al. 2010, Somfai et al. 2003, Sugimura et al. 2015) 
  None (Appeltant et al. 2015, Park and Yu 2013) 
iAC Bovine Improved (Guixue et al. 2001, Luciano et al. 2004, Luciano et al. 1999) 
 Bovine None (Aktas et al. 1995) 
Forskolin Human Improved (Shu et al. 2008) 
Murine Improved (Albuz et al. 2010, Richani et al. 2014b, Zeng et al. 2013, Zeng et al. 2014) 
Bovine Improved (Albuz et al. 2010, Ali and Sirard 2005, Li et al. 2016) 
Bovine None/Decreased (Bernal-Ulloa et al. 2016, Guimaraes et al. 2015, Ulloa et al. 2014) 
Ovine Improved (Rose et al. 2013) 
Ovine None (Buell et al. 2015) 
* Relative to standard IVM control. As assessed by embryo development typically to the blastocyst stage.  
Abbreviations: IBMX, 3-isobutyl-1-methylxanthine; CNP, C-type natriuretic peptide; iAC, invasive adenylate cyclase; dbcAMP, dibutyryl cAMP. 
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